22 December 2025 - Pharma associations form emergency committee to demand delay and joint review of planned generic price cuts.
Tensions are rising between the government and the pharmaceutical-bio industry over how to calculate the prices of generics—copycat drugs developed with the same ingredients and dosages as new drugs whose patents have expired.